NCT01956305View on ClinicalTrials.gov

Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

DS-7309

DS-7309 powder in bottle

DRUG

placebo

placebo to match DS-7309 powder in bottle

DRUG

Metformin

Metformin 500mg tablet for Cohort F

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY

NCT01956305 - Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study | Biotech Hunter | Biotech Hunter